📰 Special Access News
Page 4 - Special Access News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Special Access. Real-time updates on events, politics, business and more.
April 26, 2023
Your World At Home. Watch CTV News Regina local news LIVE right here.
April 21, 2023
Lawn Love decided to determine which US cities are the best for book lovers.
April 20, 2023
“We build electronic warfare officers based on platforms ... when that's not the best way to do that," Col. Joshua Koslov said.
April 15, 2023
Decision is with Ottawa whether to open up compassionate access to the drug through a federal program already granting some Canadians the right to legally use psilocybin
March 30, 2023
Study successfully achieved both primary and secondary objectives ANAVEX®2-73 treatment resulted in improvements of all efficacy endpoints over 48 Weeks Anavex plans to proceed to... | March 30, 2023
March 24, 2023
The Filament Health facility looks like something out of The Last of Us
March 8, 2023
Critics say a program opening up patient access to psilocybin is a bureaucratic mess. Others say caution is appropriate.
February 9, 2023
The wholly-owned Creso Pharma subsidiary is currently conducting clinical trials of its synthetic psilocybin formulation as treatment for mental health conditions NEDLANDS, Australia, Feb. 9, 2023 /PRNewswire/ --Creso Pharma Limited(ASX:CPH, FRA:1X8) ('Creso Pharma') is pleased to announce its wholly-owned psychedelics subsidiary, Halucenex Life Sciences Inc. ('Halucenex'), is exploring opportunities to register its synthetic psilocybin formulation for the Australian market follo...
February 8, 2023
/PRNewswire/ -- Creso Pharma Limited (ASX:CPH, FRA:1X8) (Creso Pharma) is pleased to announce its wholly-owned psychedelics subsidiary, Halucenex Life...
February 8, 2023
The wholly-owned Creso Pharma subsidiary is currently conducting clinical trials of its synthetic psilocybin formulation as treatment for mental health conditions NEDLANDS, Australia, Feb. 9, 2023 /PRNewswire/ -- Creso Pharma Limited (ASX:CPH, FRA:1X8) ('Creso Pharma') is pleased to announce its wholly-owned psychedelics subsidiary, Halucenex Life Sciences Inc. ('Halucenex'), is exploring opportunities to register its synthetic psilocybin formulation for...